Health New clot inhibitor offers tantalising hope to COVID-19 patients

New clot inhibitor offers tantalising hope to COVID-19 patients

A drug pioneered by researchers at Monash University could save millions of lives by preventing heart attack and stroke –  and might also be useful in the treatment of COVID-19.

It inhibits the formation of blood clots which can cause fatal blockages in the heart and brain.

Blood thinning medications like aspirin don’t work for everyone and can cause serious side effects from bleeding.

Monash University’s Associate Professor Justin Hamilton says although it’s early days, the drug might also have a role in preventing the clotting that’s caused by COVID-19.

“The possibility of using our newly developed anti-thrombotic to improve the treatment of COVID-19 patients is an appealing idea we would like to explore,” Professor Hamilton said.

Make sure your support for our universities flows through – sign the petition to #KeepItClever now.